Promising Five-Year Results for a New Minimally Invasive BPH Treatment: Optilume BPH

Benign Prostatic Hyperplasia (BPH), or enlarged prostate, affects many men as they age, causing urinary symptoms that disrupt daily life. These symptoms include a weak urinary stream, frequent urges to urinate, urgency, waking at night to urinate, and the feeling of incomplete bladder emptying. Finding treatments that offer lasting relief without major surgery or ongoing medication is a priority for many men.

At the 2026 American Urological Association Annual Meeting, Steven A. Kaplan and his team shared encouraging five-year results for a new minimally invasive treatment called Optilume BPH. This treatment offers hope for men seeking durable symptom relief with fewer side effects and less recovery time.

What Is Optilume BPH?

Optilume BPH is a drug-device combination designed to open the narrowed prostate channel that causes urinary blockage. The procedure uses a specially designed balloon that gently expands the obstructed area of the prostate. While the balloon is inflated, it delivers a medication called paclitaxel directly to the tissue. Paclitaxel helps prevent the prostate tissue from re-narrowing, aiming to keep the urinary passage open over the long term.

This approach targets the root cause of urinary symptoms in BPH with a minimally invasive technique. It avoids the need for more invasive surgery and may reduce or eliminate the need for ongoing medication.

Key Findings from the Five-Year Study

The study tracked 80 men treated with Optilume BPH at several centers in Latin America. Of these, 53 patients completed the full five-year follow-up. The results showed sustained improvements in urinary function and quality of life:

• Symptom scores improved significantly compared to before treatment and stayed improved through five years.

• Quality of life measures showed lasting benefits, reflecting better daily comfort and fewer disruptions.

• Urinary flow rates increased substantially and remained higher than baseline at the five-year mark.

  
  

Only a few patients needed additional treatment during the study period:

• One patient required further surgery.

• Two patients restarted medication for BPH symptoms.

  
  

These outcomes suggest that many men experienced meaningful, long-lasting relief after a single Optilume BPH procedure.

Optilume Balloon Dilation mehcanism.

Why Durability Matters in BPH Treatments

Many minimally invasive BPH treatments show good short-term results but struggle to maintain benefits over several years. Men want solutions that last without repeated procedures or long-term medication use. The five-year data for Optilume BPH is promising because it demonstrates sustained symptom relief and improved urinary flow over a significant period.

Durability reduces the burden on patients, lowers healthcare costs, and improves quality of life. Men can avoid the risks and recovery time associated with more invasive surgeries like transurethral resection of the prostate (TURP).

How Optilume BPH Compares to Other Treatments

Traditional BPH treatments include medications, minimally invasive procedures, and surgery. Each has pros and cons:

• Medications such as alpha-blockers and 5-alpha reductase inhibitors can reduce symptoms but often require lifelong use and may cause side effects.

• Minimally invasive procedures like UroLift or Rezūm offer symptom relief with less recovery time but may not last as long.

• Surgery like TURP is effective but involves longer recovery and higher risk of complications.

  
  

Optilume BPH offers a middle ground by combining a minimally invasive approach with a drug delivery system to improve durability. The five-year results suggest it may provide longer-lasting relief than some other minimally invasive options, with fewer side effects than surgery.

What Patients Can Expect from Optilume BPH

Men considering Optilume BPH should understand the procedure and potential outcomes:

• The procedure is typically outpatient and takes less than an hour.

• Recovery time is short, with many men returning to normal activities quickly.

• Urinary symptoms often improve within weeks.

• Long-term benefits may reduce or eliminate the need for medications or further surgery.

• Side effects are generally mild and temporary, such as minor discomfort or urinary irritation.

  
  

Discussing individual health status and treatment goals with a urologist is essential to determine if Optilume BPH is a suitable option.

Looking Ahead: The Future of BPH Treatment

The five-year data on Optilume BPH marks an important step in improving care for men with enlarged prostate. Ongoing research will continue to refine the procedure and explore its use in broader patient groups.

Men seeking relief from BPH symptoms now have more options that balance effectiveness, safety, and quality of life. Treatments like Optilume BPH show how combining mechanical and drug therapies can enhance long-term outcomes.